Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
Related Posts
Elon Musk says he and Trump are shutting down USAID
Musk did not say what legal authority he believed the White House has to shut down a federal agency without congressional approval.
House Democrats say GOP caved to Musk in funding bill, protecting his China interests
The funding bill that Congress passed over the weekend could have gone further if not for Elon Musk’s influence over Republicans, House Democrats say.
Best stocks: The 10 most exciting names of the summer and one more on the verge of a breakout
Josh and Sean take a look at the best stocks on their Best Stocks in the Market list so far this summer.